Literature DB >> 17085881

Effects of high-K+, Na+-deficient solution on contractility of the smooth muscles of the bovine trachea.

Takeharu Kaneda1, Reiko Sakaguchi, Kazumasa Shimizu, Norimoto Urakawa, Shinjiro Nakajyo.   

Abstract

A high-K+, Na+-deficient (I-154 K+) solution induced contraction followed by gradual relaxation of the smooth muscles of the bovine trachea, while hyperosmotic addition of 65 mM KCl induced a large sustained contraction. Exposure of the muscle to the I-154 K+ solution induced an increase in the ratio of cellular water content and a sustained increase in oxidized flavoprotein fluorescence or reduced pyridine nucleotide fluorescence. The I-154 K+ solution also induced a sustained increase in [Ca2+]i level. Decreases in developed tension and increases in cellular water content were both prevented by the addition of sucrose or NaCl but not pyruvate. Substitution of KI for KCl in the I-154 K+ solution produced a greater inhibition of contraction, while substitution with K-propionate produced no inhibition of contraction. Moreover, decreases in developed tension and increases in cellular water content were both prevented by addition of 100 microM 4,4'-diisothiocyanatostilbene-2,2'-disulphonic acid (DIDS), but not 10 microM bumetanide or 1 mM acetazolamide. In conclusion, I-154 K+ solution induced-relaxation in the bovine trachea may be due to swelling of smooth muscle cells and the mechanism of swelling is probably involved in DIDS-sensitive anion movement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085881     DOI: 10.1292/jvms.68.1039

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  1 in total

1.  Phloridzin inhibits high K+-induced contraction via the inhibition of sodium: glucose cotransporter 1 in rat ileum.

Authors:  Hidenori Kanda; Takeharu Kaneda; Akira Kawaguchi; Noriyasu Sasaki; Tsuyoshi Tajima; Norimoto Urakawa; Kazumasa Shimizu; Hiroetsu Suzuki
Journal:  J Vet Med Sci       Date:  2017-02-11       Impact factor: 1.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.